Literature DB >> 15743370

Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy.

Osvaldo Borrelli1, Gennaro Salvia, Valentina Mancini, Lucio Santoro, Francesca Tagliente, Erminia Francesca Romeo, Salvatore Cucchiara.   

Abstract

OBJECTIVES: Although muscular dystrophy (MD) affects primarily striated muscles, smooth muscle cells of the gastrointestinal tract may also be involved. We recorded gastric electrical activity and gastric emptying time (GET) in children with MD at initial presentation and at 3-yr follow-up in order to detect gastric motor abnormalities and study their evolution along the clinical course.
METHODS: Twenty children with MD (median age: 4.6 yr; range age: 3-7 yr) were investigated by means of ultrasonography, for measuring GET, and by electrogastrography (EGG); 70 children served as controls.
RESULTS: Ten patients had Duchenne muscular dystrophy (DMD) and 10 Becker muscular dystrophy (BMD). GET was significantly more delayed in MD patients (DMD, median: 195 min; range 150-260 min; BMD, median: 197 min; range: 150-250 min) than in controls (median: 150 min; 110-180 min; p < 0.05); it markedly worsened at the follow-up in DMD (median: 270 min; range 170-310 min; p < 0.001 vs controls) but not in BMD patients (median: 205 min; 155-275 min; p < 0.05 vs DMD). Baseline EGG showed a significantly lower prevalence of normal rhythm and significantly higher prevalence of dysrhythmias in both groups of patients as compared to controls (% of normal rhythm: DMD 66.7 +/- 8.2, BMB 67.2 +/- 11.5, controls 85.3 +/- 7.2, p < 0.001; % of tachygastria: DMD 28.4 +/- 8.0, BMB 29.8 +/- 12.3, controls 10.6 +/- 5.1, p < 0.001; % of dominant frequency instability coefficient: DMD 36.1 +/- 6.0, BMB 33.2 +/- 2.9, controls 17.9 +/- 7.1, p < 0.001); furthermore, no difference in fed-to-fasting ratio of the dominant EGG power was found between the two groups and controls (DMD 2.84 +/- 1.27, BMB 2.82 +/- 0.98, controls 3.04 +/- 0.85, ns). However, at the follow-up no significant change in the prevalence of normal rhythm and dysrhythmias occurred in both groups (ns vs baseline values), whereas only DMD patients showed a marked reduction in fed-to-fasting power ratio (0.78 +/- 0.59; p < 0.001 vs controls and BMD; p < 0.05 vs baseline), which correlated with the progressive neuromuscular weakness occurring in DMD subjects (r, 0.75; p < 0.001).
CONCLUSIONS: In children with MD, there is an early abnormality in gastric motility that is due to deranged regulatory mechanisms, whereas contractile activity of smooth muscle cells seems to be preserved. At the follow-up, DMD patients exhibited a progressive failure in neuromuscular function, which was accompanied by a gastric motility derangement with worsening in GET and in EGG features suggesting an altered function of gastric smooth muscle cells.

Entities:  

Mesh:

Year:  2005        PMID: 15743370     DOI: 10.1111/j.1572-0241.2005.41303.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

Review 1.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

2.  Liquid formulation of pentoxifylline is a poorly tolerated treatment for duchenne dystrophy.

Authors:  Angela Zimmerman; Paula R Clemens; Carolina Tesi-Rocha; Anne Connolly; Susan T Iannaccone; Nancy Kuntz; Adrienne Arrieta; Lauren Hache; Erik Henricson; Fengming Hu; Jill Mayhew; Diana M Escolar
Journal:  Muscle Nerve       Date:  2011-06-14       Impact factor: 3.217

Review 3.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

4.  Gastric emptying, small intestinal transit and fecal output in dystrophic (mdx) mice.

Authors:  Flavia Mulè; Antonella Amato; Rosa Serio
Journal:  J Physiol Sci       Date:  2009-09-26       Impact factor: 2.781

Review 5.  Gastrointestinal motility disorders in neurologic disease.

Authors:  Michael Camilleri
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

6.  Muscular dystrophies at different ages: metabolic and endocrine alterations.

Authors:  Oriana Del Rocío Cruz Guzmán; Ana Laura Chávez García; Maricela Rodríguez-Cruz
Journal:  Int J Endocrinol       Date:  2012-06-03       Impact factor: 3.257

7.  Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy.

Authors:  Christian M Lo Cascio; Oliver Goetze; Tsogyal D Latshang; Sena Bluemel; Thomas Frauenfelder; Konrad E Bloch
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

8.  Dysphagia in Duchenne muscular dystrophy: practical recommendations to guide management.

Authors:  Michel Toussaint; Zoe Davidson; Veronique Bouvoie; Nathalie Evenepoel; Jurn Haan; Philippe Soudon
Journal:  Disabil Rehabil       Date:  2016-01-05       Impact factor: 3.033

Review 9.  Nutritional Challenges in Duchenne Muscular Dystrophy.

Authors:  Simona Salera; Francesca Menni; Maurizio Moggio; Sophie Guez; Monica Sciacco; Susanna Esposito
Journal:  Nutrients       Date:  2017-06-10       Impact factor: 5.717

10.  Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice.

Authors:  Marie Nearing; James Novak; Terence Partridge
Journal:  PLoS Curr       Date:  2018-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.